UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Sporanox-10mgml-Solution-SE-IS-APD - XML Representation

Raw xml | Download



<AdministrableProductDefinition xmlns="http://hl7.org/fhir">
  <id value="Sporanox-10mgml-Solution-SE-IS-APD"/>
  <meta>
    <profile
             value="http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: AdministrableProductDefinition Sporanox-10mgml-Solution-SE-IS-APD</b></p><a name="Sporanox-10mgml-Solution-SE-IS-APD"> </a><a name="hcSporanox-10mgml-Solution-SE-IS-APD"> </a><a name="hcSporanox-10mgml-Solution-SE-IS-APD-en-US"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href="MedicinalProductDefinition-Sporanox-10mgml-Solution-SE-IS-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100003163-00013358,http://ema.europa.eu/fhir/eurdId#1798; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Oral solution; indication = Sporanox oral lösning är indicerad: - för behandling av oral och/eller esofageal candidiasis hos HIV-positiva patienter eller andra  patienter med nedsatt immunförsvar. - som profylax, mot djupa svampinfektioner som förutses vara itrakonazolkänsliga, hos  patienter med hematologisk malignitet eller som genomgår benmärgstransplantation och som  förväntas bli neutropena (dvs. &lt;0,5 x 109 /l) när standardterapi anses olämplig. För närvarande  är data över klinisk effekt vid aspergillosprofylax otillräckliga. Hänsyn ska tas till nationella och/eller lokala behandlingsrekommendationer för antimykotika.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = J02AC02</a></p><p><b>administrableDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073646}">Oral solution</span></p><p><b>producedFrom</b>: <a href="ManufacturedItemDefinition-Sporanox-10mgml-Solution-SE-IS-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Oral solution; unitOfPresentation = Bottle</a></p><h3>RouteOfAdministrations</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Code</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}">Oral use</span></td></tr></table></div>
  </text>
  <status value="active"/>
  <formOf>🔗 
    <reference
               value="MedicinalProductDefinition/Sporanox-10mgml-Solution-SE-IS-MPD"/>
  </formOf>
  <administrableDoseForm>
    <coding>
      <system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
      <code value="100000073646"/>
      <display value="Oral solution"/>
    </coding>
  </administrableDoseForm>
  <producedFrom>🔗 
    <reference
               value="ManufacturedItemDefinition/Sporanox-10mgml-Solution-SE-IS-MID"/>
  </producedFrom>
  <routeOfAdministration>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/v1/lists/100000073345"/>
        <code value="100000073619"/>
        <display value="Oral use"/>
      </coding>
    </code>
  </routeOfAdministration>
</AdministrableProductDefinition>